ACE-536-LTFU-001 (#1155)
Laufzeit: 01.01.2020 - 31.12.2040
Kurzfassung
A phase 3B, open-label, single-arm, rollover study to evaluate long-term safety in subjects who have participated in other Luspatercept (ACE-536) clinical trials
Laufzeit: 01.01.2020 - 31.12.2040
A phase 3B, open-label, single-arm, rollover study to evaluate long-term safety in subjects who have participated in other Luspatercept (ACE-536) clinical trials
